"You don't have to fight cancer alone. At CAMC, you will find oncologists, nurses and a comprehensive team of cancer specialists who are dedicated to helping you get the care you need. As West Virginia’s leading provider of cancer services, CAMC offers the highest level of care in a supportive environment close to home. By using state-of-the-art technology, our highly trained specialists treat many types of cancer, from colorectal, liver and kidney to breast, prostate and lung cancer. Our expert team of surgeons, medical oncologists, genetic counselors, nurse navigators and social workers are committed to making sure you get the best treatment possible."

During the past decade, David Lee Cancer Center at Charleston Area Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "David Lee Cancer Center at Charleston Area Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "David Lee Cancer Center at Charleston Area Medical Center" are "Breast Cancer" (2 trials). Many other conditions were trialed in "David Lee Cancer Center at Charleston Area Medical Center" in a lesser frequency.

Most popular intervention types in "David Lee Cancer Center at Charleston Area Medical Center" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Raloxifene" (1 trials), "Tamoxifen" (1 trials), "adriamycin" (1 trials), "cyclophosphamide" (1 trials) and "herceptin" (1 trials). Other intervention names were less common.

The vast majority of trials in "David Lee Cancer Center at Charleston Area Medical Center" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "David Lee Cancer Center at Charleston Area Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in David Lee Cancer Center at Charleston Area Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in David Lee Cancer Center at Charleston Area Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".